12-Month Lobbying Summary - Organization

Canadian Generic Pharmaceutical Association (CGPA) / James Keon, President

Registration Summary

Currently active - Last Updated: 2025-11-16

Who is lobbying?

Canadian Generic Pharmaceutical Association (CGPA) (Address & business activities)

James Keon, President

Government Funding

Did Canadian Generic Pharmaceutical Association (CGPA) receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

Canadian Generic Pharmaceutical Association (CGPA) is working together with the following other entities for the purpose of lobbying:

ACIC Pharmaceuticals (Address information)
Apotex Inc. (Address information)
Auro Pharma Inc. (Address information)
Baxter Canada (Address information)
Biocon Biologics Canada Inc. (Address information)
Fresenius Kabi Canada (Address information)
Juno Pharma Canada Inc. (Address information)
Mantra Pharmaceuticals Inc. (Address information)
Marcan Pharmaceuticals Inc. (Address information)
Minakem Canada (Address information)
Mint Pharmaceuticals Inc. (Address information)
Natco Pharma (Canada) Inc. (Address information)
Organon Canada Inc. (Address information)
Pharmascience Inc. (Address information)
Sandoz Canada Inc. (Address information)
SteriMax Inc. (Address information)
Sun Pharma Canada Inc. (Address information)
Teva Canada Limited (Address information)
Viatris Inc. (Address information)

Direct Interests of the Lobbying Activity

Affiliates

Canadian Generic Pharmaceutical Association (CGPA) has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

ACIC Pharmaceuticals (Address information)
Apotex Inc. (Address information)
Auro Pharma Inc. (Address information)
Baxter Canada (Address information)
Biocon Biologics Canada Inc. (Address information)
Fresenius Kabi Canada (Address information)
Juno Pharma Canada Inc. (Address information)
Mantra Pharmaceuticals Inc. (Address information)
Marcan Pharmaceuticals Inc. (Address information)
Minakem Canada (Address information)
Mint Pharmaceuticals Inc. (Address information)
Natco Pharma (Canada) Inc. (Address information)
Organon Canada Inc. (Address information)
Pharmascience Inc. (Address information)
Sandoz Canada Inc. (Address information)
SteriMax Inc. (Address information)
Sun Pharma Canada Inc. (Address information)
Teva Canada Limited (Address information)
Viatris Inc. (Address information)

Other Affiliates

The activities of Canadian Generic Pharmaceutical Association (CGPA) are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Canadian Generic Pharmaceutical Association (CGPA):

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Accelerating listing of generic drugs through regulatory reform.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Addressing and minimizing use of brand coupon cards.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Addressing and minimizing use of brand coupon cards. Commencement of negotiations to renew Agreement with pan-Canadian Pharmaceutical Alliance, including potential framework on biosimilars.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
BC's biosimilar initiative and increasing market share of biosimilars products in British Columbia.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Commencement of negotiations to renew Agreement with pan-Canadian Pharmaceutical Alliance, including potential framework on biosimilars.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Creation of a Biosimilars pricing framework in conjunction with pCPA.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discussions of British Columbia's position on the National Pharmacare initiative in a manner congruent with the interests of generic pharmaceutical manufacturers.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Encouraging British Columbia to direct the pan Canadian Pharmaceutical Alliance to negotiate a sustainable pricing regime with the generic manufacturing sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Expansion of reimbursement criteria by the Government of British Columbia for biosimilar products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Improved demand forecasts and purchasing commitments from hospitals	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Maintenance of bilateral meetings between the Ministry of Health and the CGPA.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Measures to strengthen Canada's domestic pharmaceutical industry	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Promoting greater utilization of generic prescription medicines.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Proposal of a pilot project to increase utilization of generic specialty products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Provincial government policy on opioid prescribing and dispensing and proper role of generic manufacturers.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Requesting firm notification of price changes for generic products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Support for CGPA position concerning Federal government trade negotiations with the United States.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Support for CGPA pricing proposals in current negotiations with pan-Canadian Pharmaceutical Alliance for renewal of agreement with pCPA.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Support for concerns relating to Canadian-specific requirement for insulin pumps for use with Biosimilar products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health
Member(s) of the BC Legislative Assembly
Provincial Health Services Authority

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Jeff Connell
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Jody Cox
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

James Keon
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Registration number: 1627-750
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

What lobbying activities have taken place in the last 12 months?
Date	Arranging a Meeting	Lobbyists	Senior Public Office Holder, Position Title \| Ministry/Provincial Entity	Subject Matters
2026-02-10	No	Jeff Connell , Jody Cox , James Keon	Ian Rongve, ADM \| Health	View
2025-10-27	No	James Keon	James McNish, Chief of Staff \| Health Hon. Josie Osborne, Minister of Health \| Pharmaceutical, Laboratory and Blood Services Division, Health Ian Rongve, ADM \| Health	View
2025-10-27	No	Jody Cox	James McNish, Chief of Staff \| Health Josie Osbourne, Minister of Health \| Health Ian Rongve, ADM \| Health	View

View all Lobbying Activity Reports

Return to 12-Month Lobbying Activity Search Results

Canadian Generic Pharmaceutical Association (CGPA) - Address & business activities

Address:

4100 Yonge Street
Suite 501
Toronto, ON M2P 2B5
Canada

Fax number: 416-223-2425

Contact information in previous versions
- 4100 Yonge Street
  Suite 501
  Toronto, BC M2P 2B5
  Canada
  
  Fax number: 416-223-2425
- 4120 Yonge Street
  Suite 501
  Toronto, BC M2P 2B5
  Canada
  
  Fax number: 416-223-2425
- 4120 Yonge Street
  Suite 409
  Toronto, BC M2P 2B8
  Canada
  
  Fax number: 416-223-2425
- 4120 Yonge Street
  Suite 409
  Toronto, ON M2P 2B8
  Canada
  
  Fax number: 416-223-2425

Description of Activities:
The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic and biosimilars medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.

Descriptions of the organization's activity in previous versions:
- The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.

Date Modified:: 2026-05-08

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Organization

Canadian Generic Pharmaceutical Association (CGPA) / James Keon, President

Who is lobbying?

Canadian Generic Pharmaceutical Association (CGPA) (Address & business activities)

Government Funding

Other Entities (working together for the purposes of lobbying) Information

Canadian Generic Pharmaceutical Association (CGPA) is working together with the following other entities for the purpose of lobbying:

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Who is being lobbied?

Ministries/Provincial Entities

Who are the lobbyists?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Organization

Canadian Generic Pharmaceutical Association (CGPA) / James Keon, President

Canadian Generic Pharmaceutical Association (CGPA) (Address & business activities)

Government Funding

Other Entities (working together for the purposes of lobbying) Information

Canadian Generic Pharmaceutical Association (CGPA) is working together with the following other entities for the purpose of lobbying:

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or benefits provided by the organization

Ministries/Provincial Entities

Canadian Generic Pharmaceutical Association (CGPA) - Address & business activities

Canadian Generic Pharmaceutical Association (CGPA) / James Keon, President

ACIC Pharmaceuticals

Auro Pharma Inc.

Apotex Inc.

Sandoz Canada Inc.

Pharmascience Inc.

Sun Pharma Canada Inc.

SteriMax Inc.

Viatris Inc.

Teva Canada Limited

Biocon Biologics Canada Inc.

Baxter Canada

ACIC Pharmaceuticals

Juno Pharma Canada Inc.

Fresenius Kabi Canada

Auro Pharma Inc.

Marcan Pharmaceuticals Inc.

Apotex Inc.

Mantra Pharmaceuticals Inc.

Biocon Biologics Canada Inc.

Mint Pharmaceuticals Inc.

Baxter Canada

Minakem Canada

Juno Pharma Canada Inc.

Organon Canada Inc.

Fresenius Kabi Canada

Natco Pharma (Canada) Inc.

Marcan Pharmaceuticals Inc.

Sandoz Canada Inc.

Mantra Pharmaceuticals Inc.

Pharmascience Inc.

Mint Pharmaceuticals Inc.

Sun Pharma Canada Inc.

Minakem Canada

SteriMax Inc.

Organon Canada Inc.

Viatris Inc.

Natco Pharma (Canada) Inc.

Teva Canada Limited